Steve Pakola, Chief Medical Officer at REGENXBIO Inc. (RGNX), sold 8,113 shares at $22.17 ($181K) on 2023-01-03, disclosed to the SEC on 2023-01-05.
Open-market sale of $181k RGNX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.17 | 3,138 | $70K | 38.5% |
| 2 | $22.17 | 3,138 | $70K | 38.5% |
| 3 | $22.68 | 1,837 | $42K | 23.0% |
| Total | $22.29 avg | 8,113 | $181K | 100% |
| Filing → |
| RGNX | SELL | 2026-05-13 | $169K | — | Filing → |
| RGNX | SELL | 2026-03-12 | $53K | — | Filing → |
| RGNX | SELL | 2024-03-07 | $730K | — | Filing → |